Edition:
United States

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

37,615.00ZAc
3:26am EDT
Change (% chg)

-87.00c (-0.23%)
Prev Close
37,702.00c
Open
37,793.00c
Day's High
37,793.00c
Day's Low
37,499.00c
Volume
24,292
Avg. Vol
1,162,561
52-wk High
38,849.00c
52-wk Low
23,364.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a South Africa-based pharmaceutical company. The Company through its subsidiaries manufactures branded and generic pharmaceutical products as well as infant milk nutritionals and consumer healthcare products in selected territories, operating primarily in the healthcare industry. The Company... (more)

Overall

Beta: 0.48
Market Cap(Mil.): R172,073.41
Shares Outstanding(Mil.): 456.40
Dividend: 216.00
Yield (%): 0.57

Financials

  APNJ.J Industry Sector
P/E (TTM): 28.40 36.15 37.05
EPS (TTM): 13.27 -- --
ROI: 9.09 15.11 14.35
ROE: 16.39 16.17 15.56

BRIEF-Aspen Pharmacare Holdings closes 3 bln euro facilities arrangements

* Aspen closes eur 3,000,000,000 equivalent facilities arrangements

Jun 08 2016

South Africa's Aspen Pharmacare signs U.S. supply deal with ANI

JOHANNESBURG Aspen Pharmacare has signed a distribution and supply agreement with ANI Pharmaceuticals to sell a female cancer treatment in the United States, the South African drugmaker said on Wednesday.

May 18 2016

South Africa's Aspen Pharmacare signs U.S. supply deal with ANI

JOHANNESBURG, May 18 Aspen Pharmacare has signed a distribution and supply agreement with ANI Pharmaceuticals to sell a female cancer treatment in the United States, the South African drugmaker said on Wednesday.

May 18 2016

BRIEF-Aspen signs agreement with ANI Pharma for distribution of HPC injection in US

* Agreement with ANI pharmaceuticals for distribution of hydroxyprogesterone caproate injection in US

May 17 2016

UPDATE 1-Drugmakers ask South African government for extra price rise - Aspen CEO

JOHANNESBURG, March 3 South African pharmaceutical companies have asked the government to approve an extra increase in medicine prices this year to compensate for a weaker rand, Aspen Pharmacare's chief executive told Reuters on Thursday.

Mar 03 2016

South Africa's Aspen Pharmacare posts 14 pct rise in H1 profit

JOHANNESBURG, March 3 South Africa's Aspen Pharmacare Holdings reported a 14 percent rise in half-year profit on Thursday as revenue growth in most international markets offset a weak showing at home.

Mar 03 2016

BRIEF-Aspen Pharmacare H1 comparable normalised HEPS rises 21 pct

* Comparable NHEPS for six months ended 31 December 2015 was 640,9 cents, an increase of 21 pct

Mar 03 2016

BRIEF-Aspen Pharmacare sees comparable NHEPS for 6 mths ended Dec. 31 up 18-23 pct

* Sees comparable NHEPS for 6 mths ended Dec. 31 between 623.6 cents and 650.1 cents, up between 18 pct and 23 pct

Feb 23 2016

BRIEF-Aspen Pharmacare buys rights to hydroxyprogesterone caproate finished dose

* Acquired intellectual property and approved abbreviated new drug application in u.s. In respect of finished dose form of hydroxyprogesterone caproate Source text for Eikon: Further company coverage:

Feb 19 2016

Earnings vs. Estimates